Q3 2019 Earnings Conference Call Q3 2019 Earnings Conference Call - PowerPoint PPT Presentation

Q3 2019 Earnings Conference Call Q3 2019 Earnings Conference Call November 25, 2019 November 25, 2019

Today’s presenters El Elisab abet Lund Gö Göran Ma Malm lmberg Gr Group CEO EO & President Ch Chief ef Financial Of Officer er

Third Quarter of 2019 Continued ex Co expansion, bu but th the med medical de device in industr try is is la laggin ing • St • Lagging decision processes in the medical device industry Strategic partnerships: : Progress with all three partners: Siemens Healthineers, Philips and Laerdal. segment impacted negatively on sales, but no Expected sales increase in 2020. opportunities were lost to competitors or disappeared. • Te Technology : New ultrasound solutions presented for • Positive indications from the hospital segment, with sales TEE (Transesophageal Echocardiography) and ICE expected to outperform 2018. (Intracardiac Echocardiography). • Intensified approach in India, could become next growth • Te Technology: Rapid progress in auto segmentation area in APAC after China and Japan. solution based on machine and deep learning, prototype expected to be ready by year-end. • Denis Gestin, Gösta Johannesson and David Ballard were elected as additional board members enhancing Mentice marketing orientation of the board. • Mentice reached 100 full-time equivalent employees.

Q3 2019 – Financial performance Or Order in inta take an and order book ook Order intake Order book Order intake for the third quarter was 24. 4 (49.2) MSEK. The order book* was 47.0 (55.0) MSEK at the end of the quarter. It is estimated that 50% of the order book will be delivered during the year. 200 180 160 140 120 100 80 60 40 20 0 Q3 2017 Q4 2017 Q1 2018 Q2 2018 Q3 2018 Q4 2018 Q1 2019 Q2 2019 Q3 2019 Order Intake RTM (MSEK) (*) The order book represents orders received but not yet delivered.

Q3 2019 – Financial Performance Ne Net sa sales pe per segment Jan–Sep 2019 Jan–Sep 2018 Full Year 2018 3% 0% 5% 30% 32% 28% 65% 67% 70%

Q3 2019 – Financial Performance Ne Net sa sales pe per pr produ duct Jan–Sep 2018 Jan–Sep 2019 Full Year 2018 30% 32% 35% 35% 38% 44% System Sales 26% 27% 33% Software Licenses Support & Service contracts

Q3 2019 – Financial Performance Ne Net sa sales pe per ge geogr ographic ma market et Me Mentice re report ports sa sales fi figures fo for th three ge geogr graphic ic ma markets: • EMEA (Europe, Middle East and Africa) • APAC (Asia and the Asian Pacific Region) • Americas (North, Central and South America)

Q3 2019 – Financial Performance Ke Key fi figur ures * * RTM = Latest 12 months period. RTM has not been reviewed by the company’s auditors.

Outlook – Fourth quarter of 2019 • We expect strong sales in the fourth quarter. • St Strategic partnerships: : In-depth discussions with However, we do not expect to reach the full year strategic partners and participation in medical target that was set forth in the Q2 report. congresses such as RSNA (Chicago) together with • Current forecast suggests that we will end up around Siemens Healthineers and Philips Healthcare. last year’s result for net sales and orders received. • Te Technology: The technology department is fully • Additional opportunities might help us bridge some of allocated and divided between custom solutions for the delta between our current forecast and the initial the medical device industry, standard simulation target. solutions for all clients and new innovative technologies such as robotics and auto • Large pipeline over and above what we expect to segmentation. close for the fourth quarter will move over and build opportunities for 2020. • Med Medic ical l Devic ice e Industr try: We expect several of our • Orders received late in the end of the year will build medical device industry projects to close during the order book for next year. fourth quarter, bridging some of the gap compared to our initial target as well as last year’s outcome.

outlook – Full year 2019 and further Ahead Di Disappoi ointing g ou outlook ook for or 2019, but stron ong g pos osition ons in all ge geogr ographies and segme gments cr create a promising view on 2020 and our co continued expansion • Disappointing outlook for 2019, but this is expected to have a minimal impact on mid-term expansion. • Mentice has a competitive position as well as market share per segment and geography. Our vertical approach is providing us with strong leverage. • We have high expectations for our interactions with strategic partners as well as the effect of new technologies planned for 2020 and onwards.

Q&A Session El Elisab abet Lund Gö Göran Ma Malm lmberg Gr Group CEO EO & President Ch Chief ef Financial Of Officer er